Our Work

Policy Engagement

our aim is to contribute to the improvement of the management and control of malaria and other communicable diseases at all levels of community and health care systems through policy Engagement



MAC supported the Ministry of Health in piloting the delivery of 100% subsidised insecticide treated nets (ITNs) to children during immunisation visits.

Over the years MAC has supported several drug efficacy study to support the adoption of ACTs as new first and second line treatment regimens and monitor their efficacy every two years. 

Following the change of malaria treatment policy, MAC supported research to assess the efficiency and feasibility of using mRDTs in the diagnosis of malaria in Malawi by comparing four mRDTs.

The study provided the link between the efficacy trials on the one hand and policy change and programme scale-up on the other. Data generated from this “real life” programme conditions led to the adoption of the program in other countries.

This study looked at the supply and availability of anti-malarials and other essential medicines in Malawi – guiding the roll out of ACTs across the country.

This study showed high prevalence of malaria and anaemia amongst school going children in Zomba district leading a large RCT to assess the impact of one intervention in schools.

The study assessed the effectiveness of ITNs on malaria incidence in an area of high resistance to pyrethroids in Machinga District, Malawi.

Two new third generation nets, Permanet 3.0 and Olyset plus, which are combination nets treated with an insecticide and a synergist potentially can be used to mitigate effects of pyrethroid resistance.

This pilot study assessed the feasibility of integrating RDTs and rectal artesunate into the Community Case Management programme being implemented by Ministry of Health – leading to the integration of RDTs and rectal artesunate into village clinics.